Quantcast
Last updated on April 24, 2014 at 10:25 EDT

Latest Anticonvulsants Stories

2013-11-04 10:36:26

Bipolar drugs lose effect during pregnancy, so women need higher doses to stay well New Northwestern Medicine® research offers one of the first in-depth studies of how physiological changes during pregnancy reduce the effects of a commonly used drug to treat bipolar disorder, making women more vulnerable to recurring episodes. The new findings will help psychiatrists and physicians prevent bipolar manic and depressive symptoms during pregnancy, which are risky for the health of the mother...

2013-11-04 08:25:48

- Results from VIMPAT® (lacosamide) monotherapy study supporting this filing to be presented at AES 2013 ATLANTA, Nov. 4, 2013 /PRNewswire/ -- UCB announced that the US Food and Drug Administration (FDA) has accepted for filing a supplemental new drug application (sNDA) for VIMPAT(®) (lacosamide) C-V as monotherapy in the treatment of partial-onset seizures in patients with epilepsy aged 17 years and older. Investigational data from the phase 3 lacosamide conversion to monotherapy study in...

2013-11-01 10:46:34

50 years after valproate was first discovered, research published today in the journal Neurobiology of Disease, reports how the drug works to block seizure progression. Valproate (variously labelled worldwide as Epilim, Depacon, Depakene, Depakote, Orlept, Episenta, Orfiril, and Convulex) is one of the world's most highly prescribed treatments for epilepsy. It was first discovered to be an effective treatment for epilepsy, by accident, in 1963 by a group of French scientists. In...

2013-10-28 23:27:09

On August 17, Bloomberg published that a federal court complaint was filed accusing Abbott Labs of racketeering in an effort to promote Depakote for unapproved uses. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Depakote side effects. San Diego, CA (PRWEB) October 28, 2013 AttorneyOne.com, a recognized authority on law, updated the website...

Cocaine Addiction Treated With Epilepsy Drug
2013-10-26 05:03:20

redOrbit Staff & Wire Reports - Your Universe Online A medication currently approved by the US Food and Drug Administration (FDA) to treat epilepsy and migraines could also be the first drug capable of effectively treating cocaine addiction, according to new research published in the journal JAMA Psychiatry. Bankole A. Johnson, chairman of the Department of Psychiatry at the University of Maryland School of Medicine, and colleagues recruited 142 adults who were seeking treatment for...

2013-10-22 23:30:57

Throughout June and August 2013, investors and health plans are going after Depakote manufacturer Abbott Laboratories with a lawsuit regarding its marketing practices. Connecticut law firm Trantolo & Trantolo, in response to this and other recent cases, is assisting with Depakote-related claims. Hartford, CT (PRWEB) October 22, 2013 On June 5, 2013, U.S. District Judge Virginia Kendall in Chicago denied a request to dismiss a lawsuit from shareholders alleging Depakote manufacturer...

2013-10-21 23:30:02

As Businessweek published on October 15, a new trial started alleging that the plaintiff's son was born with birth defects resulting from her use of Topamax. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Topamax side effects. San Diego, CA (PRWEB) October 21, 2013 AttorneyOne.com, a recognized authority on law, updated the website...

2013-10-15 12:31:39

Findings Support Tolerability and Consistent Pharmacokinetic Profile of Once-Daily USL255 MAPLE GROVE, Minn., Oct. 15, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., (Upsher-Smith) announced the presentation of Phase 1 data supporting the favorable tolerability and consistent, predictable pharmacokinetic (PK) profile of its investigational drug, USL255 (extended-release topiramate) following single-dose administration to healthy subjects. USL255 is being developed by...

2013-09-25 08:30:42

SAN DIEGO, Sept. 25, 2013 /PRNewswire-USNewswire/ -- Current estimates indicate that autism spectrum disorder affects 1 in 88 children, and that the incidence of this disorder is continuing to rise. Medical abnormalities associated with autism are being increasingly recognized. Seizures affect a substantial portion; some estimates suggest that up to 1/3 of children with autism may eventually develop seizures. The incidence of seizures appears to increase with age, becoming more...

Propofol Breakthrough New Anesthetics
2013-09-23 09:33:59

Brett Smith for redOrbit.com - Your Universe Online New research from an international team of scientists has revealed the specific chemical mechanism behind the anesthetic propofol, the drug widely known for being implicated in the death of music icon Michael Jackson. According to a report published in the journal Nature Chemical Biology, the international team located the specific site on the brain where propofol binds to receptors and sedates patients before surgery. "For many...